Pharmaceutical research and development.
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.
Visit website: https://www.abbvie.com/
CollPlant gains $10m milestone from AbbVie to develop dermal and soft tissue filler
Longevity Technology - 04-Jul-2023
Recombinant human collagen based fillers help advance the field regenerative aestheticsRead more...
AbbVie and Calico extends their collab up to 2025 with a $1 billion deal
FierceBiotech - 27-Jul-2021
Supports ageing research and advancing early-stage projects to phase 2 trials over the next decadeRead more...
Calico and AbbVie announced early-stage trials for new therapies
Calico - 03-Feb-2021
Clinical trials in progress for potential targets of cancer and neurodegenerative diseasesRead more...
Calico partners with AbbVie to develop a cancer drug
San Francisco Business Times - 19-Oct-2020
Ex-Genentech CEO's drug company starts first clinical trial of cancer researchRead more...
Silicon Valley and rich people invest to slow down ageing and live longer
This Is Money - 17-Mar-2018
All the money in the world to fight ageing and deathRead more...
Doctors promoting treatments on social media fail to disclose ties to drug makers
STAT - 29-Feb-2016
US physicians often fail to mention that they have accepted thousands of dollars from the compani...Read more...